Rene Lerer Insider Profile
4 Followers
Rene Lerer, former Director at Immune Pharmaceuticals, holds 0.00 shares in Immune Pharmaceuticals (Ticker: IMNPQ), holds 84.09K shares in Magellan Health (Ticker: MGLN).
Rene Lerer's Trading History
| MGLNMagellan Health | Dec 09, 2013 | ― | Uninformative Sell | 412.42K | $7.99M | |
| IMNPQImmune Pharmaceuticals | ― | ― | ― | $0.00 |
You May Also Like
Rene Lerer insider profile FAQ
What is the percentage of profitable transactions made by Rene Lerer?
The percentage of profitable transactions made by Rene Lerer is 86%.
What is the average return per transaction made by Rene Lerer?
The average return per transaction made by Rene Lerer is 1.50%.
What stocks does Rene Lerer hold?
Rene Lerer holds: IMNPQ, MGLN stocks.
What was Rene Lerer's most profitable transaction?
Rene Lerer’s most profitable transaction was an Informative Buy of MGLN stock on November 12, 2013. The return on the trade was 3.70%.
What is Rene Lerer's role in Immune Pharmaceuticals?
Rene Lerer's role in Immune Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
